That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
Daily limit reached
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the
maps, the
directory and
search do
not count against this, and neither does re-opening something you have
already read today.
Sonus Microsystems and Medtronic have partnered to integrate Sonus's AI-powered wearable ultrasound device, the Sonus Patch™, with Medtronic’s monitoring technology for a field study in Kenya aimed at screening pregnant women for early-onset preeclampsia. The collaboration seeks to provide critical cardiac data using non-invasive methods and aims to make advanced monitoring accessible in areas lacking specialized medical personnel.
Written by the local model on 2026-09-16,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
Sonus Microsystems, a technology company based in Vancouver, British Columbia, partnered with Medtronic, a global leader in healthcare technology located in Lafayette, Colorado, to integrate the Sonus Patch™. This AI-powered wearable ultrasound platform will be combined with Medtronic's acute care and monitoring technologies. The collaboration aims to evaluate an integrated non-invasive system through field studies in Kenya starting from September 15, 2026. The goal is to provide clinically relevant cardiac and hemodynamic data for pregnant women at risk of early-onset preeclampsia, especially in areas lacking specialized medical resources. Hani Eskandari, CEO of Sonus Microsystems, emphasized the importance of making advanced monitoring accessible worldwide, highlighting the potential impact on cardiac care delivery in underserved regions.
Written for “AI Maternal Health Partnership” on 2026-09-17,
grounded in this article and the 0 other(s) covering the same event.
Why this leaning score
This article does not take a side on a contested political
question, so it has no leaning score. That is an
answer rather than a gap: a match report or a rescue can be warmly
or critically written without being left or right, and scoring it
anyway is how approval of a subject gets recorded as a political
position.
No political leaning scored for article 10805 · logged 2026-09-16
Sonus Microsystems today announced a collaboration with Medtronic, the global leader in healthcare technology, to integrate the Sonus Patch™, an AI-powered wearable ultrasound platform, with technology from the Acute Care & Monitoring operating unit at Medtronic.
asserted
Microsystems → announce → Medtronic
The collaboration will evaluate an integrated, non-invasive monitoring system in field studies in Kenya.
asserted
collaboration → evaluate → Kenya
Together, the technologies aim to provide clinically relevant cardiac and hemodynamic data to support the screening and triage of pregnant women at risk of early-onset preeclampsia.
asserted
technologies → aim → preeclampsia
“Our goal is to make advanced cardiac monitoring accessible regardless of where patients live,” said Hani Eskandari, CEO of Sonus Microsystems.
asserted
Eskandari → make → Microsystems
“By making ultrasound autonomous, we can expand who can deliver an ultrasound and where it can be delivered, including in settings where a specialized sonographer is not available.
asserted
sonographer → make → settings
We are proud to be working with Medtronic and the Gates Foundation to validate our platform in high-impact applications and address critical gaps in cardiac care delivery.”
asserted
We → work → delivery
The Aporia
